resources

Enabling SEDDS Formulation Choice through In Vitro-In Vivo Correlation with BASF and Pion

Enabling SEDDS Formulation Choice through In Vitro-In Vivo Correlation with BASF and Pion

Webinar

Preview - This content has been restricted to logged in users only.

Absorption rate of the Active Pharmaceutical Ingredient (API) can be enhanced by fine tuning the composition of SEDDS.
Enabling SEDDS Formulation Choice through In Vitro-In Vivo Correlation with BASF and Pion

Webinar

In this webinar, you can learn the steps BASF took, in partnership with Pion, in developing enhanced SEDDS formulations based on their surfactant emulsion properties, including droplet size and hydrophilicity. BASF generated in vitro information via Pion technology, and as a result, were able to report enhanced IVIVC performance for SEDDS formulations.

Previous post